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Abstract
Debate surrounds the question of whether the heart is a post-mitotic organ in part due to the lack of an in vivo model in
which myocytes are able to actively regenerate. The current study describes the first such mouse model — a fetal
myocardial environment grafted into the adult kidney capsule. Here it is used to test whether cells descended from bone
marrow can regenerate cardiac myocytes. One week after receiving the fetal heart grafts, recipients were lethally irradiated
and transplanted with marrow from green fluorescent protein (GFP)-expressing C57Bl/6J (B6) donors using normal B6
recipients and fetal donors. Levels of myocyte regeneration from GFP marrow within both fetal myocardium and adult
hearts of recipients were evaluated histologically. Fetal myocardium transplants had rich neovascularization and beat
regularly after 2 weeks, continuing at checkpoints of 1, 2, 4, 6, 8 and12 months after transplantation. At each time point,
GFP-expressing rod-shaped myocytes were found in the fetal myocardium, but only a few were found in the adult hearts.
The average count of repopulated myocardium with green rod-shaped myocytes was 996.8 cells per gram of fetal
myocardial tissue, and 28.7 cells per adult heart tissue, representing a thirty-five fold increase in fetal myocardium compared
to the adult heart at 12 months (when numbers of green rod-shaped myocytes were normalized to per gram of myocardial
tissue). Thus, bone marrow cells can differentiate to myocytes in the fetal myocardial environment. The novel in vivo model
of fetal myocardium in the kidney capsule appears to be valuable for testing repopulating abilities of potential cardiac
progenitors.
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Introduction
For many years, the common textbook beliefs have been that
no new cardiac myocytes are generated after birth in mammals;
that cardiac myocytes are terminally differentiated, beat contin-
uously and rarely fatigue or die; and that the heart increases in
size only through hypertrophy. These beliefs were supported by
the absence of mitotic figures in myocytes as well as the absence
of new cardiac myocytes after cell loss caused by infarction.
Recent studies, however, have challenged these beliefs, suggesting
that cardiac myocytes are replaced throughout the lifespan [1–5],
that myocytes can regenerate from resident cardiac progenitor
cells (CPCs) [6] as well as from bone marrow [3,7–12], and that
the human heart contains cycling myocytes undergoing mitosis
and cytokinesis under normal and pathological conditions
[1,2,13]. Nevertheless, the importance of myocardial regenera-
tion to cardiac health remains controversial, and the absence of
an in vivo model in which myocytes are actively regenerating has
been a significant obstacle in characterizing cardiac progenitor
cells.
During normal development, CPCs actively proliferate and
differentiate into cardiac myocytes in the fetal myocardium. In the
present study, we created an in vivo model — fetal myocardium
within the kidney capsule — which beat continuously for 12
months. We applied this model to examine the hypothesis that
bone marrow with green fluorescence protein (GFP) expression
could regenerate cardiomyocytes, thus producing myocytes. As
predicted, significant numbers of GFP-expressing rod-shaped
myocytes were observed in the fetal myocardium model from 2
weeks to 12 months after irradiation and GFP-labeled marrow
transplantation.
Materials and Methods
Animals
Animal study protocols were approved by the IACUCs at the
University of Minnesota and The Jackson Laboratory (Bar
Harbor, ME). Mice were produced, and surgery, irradiation and
marrow transplantation were performed in the D1 barrier colony
at The Jackson Laboratory (Bar Harbor, ME). Mice were fed an
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31099irradiated formulation of the NIH-31 (4% fat) diet, Purina
LabDiet’s 5LG6 (TestDiet inc. Richmond, IN). All mice were on
the C57Bl/6J (B6) (JAXH Mice stock # 000664) inbred strain
background. GFP-marked marrow donors were C57BL/6-
Tg(UBC-GFP)30Scha/J (JAXH Mice stock # 004353).
Fetal heart transplantation
B6 mice at 10–12 weeks of age, ranging from 30–40 g in weight,
were given 0.60–0.85 ml tribromoethanol anesthetic diluted in
sterile phosphate buffered saline by intraperitoneal injection
(400 mg/kg, ip). The fur was then clipped from an area about
5c m
2, providing a surgical field that was disinfected with 70%
ethanol and betadine. Rimadyl (Carprofen, Pfizer) was diluted to a
working dilution of 0.5 mg/ml with sterile water and given
subcutaneously (5 mg/kg). The mouse was then placed in the right
lateral recumbent position. A 5–8 mm incision in the skin was
made below the lowest rib, exposing the abdominal wall; a 4–
7 mm incision was then made in the abdominal wall. The kidney
was exposed and elevated. A small cut was made in the capsule
over the lateral border of the kidney with a #5 Dumont forceps
and enlarged as the fetal heart (E12–E16 from same background)
was inserted deeply into the capsule. The kidney was then replaced
in its normal position and the incisions in skin and abdominal wall
were closed with 5-0 absorbable suture. Mice were then given
0.5 ml sterile PBS ip and placed under a warming lamp until they
responded and moved normally.
Lethal irradiation and bone marrow transplantation
Seven days after fetal hearts were transplanted, mice were
lethally irradiated (1100 rads at a rate of 100 rad/min) using a Cs-
137 Shephard (J. L. Shephard & Associates, Glendale, CA) model
irradiator, to remove normal precursor cells so they could be
replaced by descendants of bone marrow cells marked with GFP.
Donor bone marrow was taken from femur and tibia, filtered
and used as single cell suspensions as described previously [14–16].
Recipients were warmed to dilate tail veins. GFP-marked marrow
cells were injected iv into the lateral tail veins with a 30 gauge
needle, giving each recipient 20 million cells. Previously in our lab,
this method of bone marrow transplantation has successfully
resulted in long-term repopulation of circulating cells derived from
GFP donors [17].
Immunohistochemistry and evaluation of cardiac
repopulation from bone marrow
Recipients that had been lethally irradiated and transplanted
with GFP
+ bone marrow were used for the evaluation of cardiac
repopulation from bone marrow. Green rod-shaped myocytes
were enumerated at 2 weeks (n=7) and at 2, 4, 6, 12 months (n=4
each) after irradiation and the marrow transplantation. Positive
and negative controls were compared using additional mice of the
same strain, sex and age. Both transplanted fetal hearts and adult
hearts were examined for GFP-marked cells. Each adult heart was
divided into ,800 sections as previously described in detail
[9,18,19], whereas kidney regions containing the fetal hearts were
divided into ,500 sections using a cryostat.
Detailed histology methods employed in this study have been
described previously [18,20,21]. Briefly, tissues were either cryo-
stained or paraffin-stained to characterize the fetal heart transplant
and to evaluate the cardiac repopulation. For cryo-staining, kidney
tissues with fetal heart transplants were embedded in Tissue-Tek
OCT compound (Sakura Finetek, Zoeterwoude, The Netherlands)
and then sectioned by cryostat (10 mm in thickness). Endothelial
marker von Willebrand factor (vWF) and cardiac marker
Troponin T (TnT) were detected using anti-vWF (abcam, 1:50
dilution) and anti-TnT antibodies (Thermo Scientific, 1:50
dilution) followed by visualization with species matched secondary
antibodies conjugated with either TRITC or FITC (Jackson
ImmunoResearch, 1:100 dilution). ProlongGold+DAPI (Invitro-
gen) was utilized for slide mounting and nuclei visualization. For
paraffin-staining, samples were fixed in 10% formalin followed by
paraffin embedding and sectioning at a 5-mm thickness. Sections
were subject to antigen retrieval using citrate buffer followed by
incubation with antibodies against GFP (Abcam, 1:20 dilution)
and a-sarcomeric actin (a-SA, Sigma Aldrich, 1:100 dilution).
Visualization of staining was achieved by incubation with species-
matched secondary antibodies conjugated with either TRITC or
FITC (Jackson ImmunoResearch, 1:100 dilution). Rod-shaped
large GFP positive cells co-stained positive with a-SA were defined
as differentiated cardiomyocytes from bone marrow. Total
numbers of GFP
+/a-SA
+ cells were counted, and data are
presented as total cells/gram myocardium. One per every
sequential ten slides was evaluated for each heart. The total count
of GFP
+ rod shaped myocytes of each organ was obtained through
multiplication by 10. All negative findings of detecting the GFP
+
cells had positive controls using the tissue/organ from eGFP mice.
All positive findings of eGFP
+ cells had their respective own
control of eGFP negative cells on the same slide.
Statistics and data analysis
Levels of myocyte regeneration from bone marrow are
represented by the number of green rod-shaped myocytes divided
by grams of myocardium, assuming that the size of the fetal heart
at E17 is 10% that of an adult heart. All values are expressed as
mean 6 standard deviation. All statistical analyses were performed
in Sigmastat version 3.5 (San Jose, CA). Rod-shaped myocyte data
were compared between the fetal and adult hearts using Student’s
t-test, using the significance level of type I error (P,0.05).
Results
Both fetal and adult hearts of recipients were evaluated at time
points ranging from 2 weeks to 12 months after irradiation and
marrow transplantation, as detailed above. Transplanted fetal
hearts beat regularly in the kidney capsule at ,70 beats per
minute at time points of 2 weeks (n=7) and 1, 2, 4, 6, 8 and 12
months (n=4, at each monthly time point) after the transplanta-
tion (Video S1). In addition, we observed vigorous neovascular-
ization of the fetal myocardium under the kidney capsule. At week
1, a mass of blood vessels was localized near the fetal heart (Figure
S1) that was a result of angiogenesis of sprouting from the
preexisting vessels as they were GFP staining negative. At 2–12
months post fetal transplantation, some of these vessels formed
small arteries with visible established circulation. No masses of
blood vessels appeared elsewhere on the kidney.
From 2 through 12 months after transplantation, the explants’
histological characteristics are similar; these are illustrated in the
first two figures. In Figure 1, Panel A shows a typical fetal heart
(arrows) on the surface of a recipient kidney 10 months after
transplantation. Panel B illustrates a cross section of this fetal heart
co-stained with vWF (green), TnT (red) and DAPI (blue). Panel C
shows a higher magnification of the fetal heart. The endocardial
cell lining is visualized by vWF staining (Panel C1). It is interesting
to note that the myocardial structure changes with rich channels
from the LV cavity which penetrate everywhere across the LV wall
(Panel C3).
Figure 2 illustrates typical staining found in fetal myocardium
in the kidney capsule 12 months after transplantation; it is
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fiber orientation (Figure 2A). Clear GFP
+ production in myocytes
with striation indicates descent from the donor bone marrow
(Figure 2 B–C). The bright green rod-shaped large myocytes with
distinct size and shape in Figure 2 B–C exclude the possibility
that these could be green fluorescent macrophages engulfing
recipient fetal origin myocytes. Myocyte differentiation from
donor marrow does occur in the adult heart, as shown in Figure 3.
In the normal adult heart, however, the very small proportion of
green myocytes indicates that bone marrow differentiation to
myocytes is a far less frequent event than in the fetal heart. To
compare these frequencies at 12 months, numbers of green rod-
shaped myocytes found in fetal hearts were compared to adult
recipient hearts. It is important to normalize the number of green
rod-shaped myocytes per gram of myocardium tissue mass, as
adult hearts are at least 10 times larger than fetal hearts. At 12-
months of age, the heart weight was 133.8624.2 mg and
12.660.7 mg for the adult- and fetal- heart, respectively. The
proportion of bone marrow descended myocytes in transplanted
fetal tissue are 34.7- fold greater than in adult hearts
(996.86774.6 vs. 28.7613.4 per gram of myocardium; Figure 4,
P,0.05). This frequency would exclude the cell fusion confound-
ing factor, as it was reported that labeled stem cells fused with
myocytes occur at a much lower frequency [22]. However, the
data from present study cannot definitively exclude the possibility
of mobilized BM cell fusion with the recipient cardiomyocyte,
which warrant future investigations.
Discussion
Increases in cardiac mass in mammals during fetal life occur
mainly due to cardiomyocyte proliferation. After birth, the heart
has been viewed as a post-mitotic organ consisting of a
predetermined number of parenchymal cells that are preserved
throughout life [23–25]. Adaptive increases in cardiac mass in
adults as a result of hemodynamic burden are achieved mainly
through increase in cell size known as hypertrophy [23–25], as
shown by the absence of mitotic figures in myocytes, plus the
observation that regions of transmural infarction evolve into
essentially avascular, thin collagenous scar tissue. These facts make
the suggestion that cardiomyocytes regenerate in adults highly
controversial.
Nevertheless, recent studies have challenged the paradigm that
heart tissue is incapable of regeneration. Adult human hearts
contain myocytes undergoing mitosis and cytokinesis under
normal and pathological conditions [13,26–29]. The heart is one
of many organ systems that constantly renews and whose capacity
to replace cells depends on the persistence of a stem cell
compartment [29–31]. Such cardiac progenitor cells (CPCs) are
responsible for the constant turnover of cardiomyocytes, endothe-
lial cells, smooth muscle cells and fibroblasts. If CPCs are active in
adults, however, why is ischemic myocardial damage not
spontaneously repaired and heart failure cured? Perhaps CPCs,
or cells essential for their support and differentiation, or both, are
especially vulnerable. Thus in the infarcted region, they die,
Figure 1. Characterization of fetal heart transplant. A: Typical fetal heart (arrows) on the surface of a recipient kidney 10 months after
transplantation into the kidney capsule. B: Cross section of this fetal heart co-stained with vWF (green), TnT (red) and DAPI (blue). C1 and C2: Higher
magnification of fetal heart visualized by vWF and TnT staining. C3: Myocardial structure changes with rich channels from the LV cavity that penetrate
everywhere across the LV wall.
doi:10.1371/journal.pone.0031099.g001
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growth only occurs in viable myocardium [26,32]. In addition,
cellular senescence may increase vulnerability to damage and limit
repair in older people [33]. Thus, a defective CPC compartment
may prevent cardiac repair whether the initiating event is ischemic
myocardial injury, aging or diabetes [34].
There are reports that cardiac myocytes can be derived from
marrow [35], specifically side population precursor cells following
LAD ligation [11,36]. Transplantation of GFP
+ lineage negative,
c-kit
+ cells (presumably containing both hematopoietic and
mesenchymal stem cell populations) into the ventricular wall after
LAD ligation improved function of the ventricle and produced
GFP cells with cardiac phenotype in the myocardium [3].
Contradicting these findings, other laboratories using genetic
markers have reported that lineage negative, c-kit
+ marrow cells
did not differentiate into cardiomyocytes [22,37]. Perhaps this
contradiction is partly resolved by our demonstration here that
bone marrow cells can differentiate to myocytes in the fetal heart
environment, but that it is a much rarer event in the adult heart.
Survival of the fetal myocardium in our studies is demonstrated
unequivocally by the regular beating (Video S1). However, even
the degree of repopulation by marrow in our fetal heart model
may represent a minimum. The unusual myocardial structural
changes with rich channels rising from the LV cavity and across
the LV wall (Figure 1C) in our model may affect myocardial
perfusion, reducing myocyte regeneration by marrow-derived
precursors. Furthermore, while the B6 recipient is nearly 100%
repopulated by hematopoietic donor cells after irradiation and
marrow grafts [14–16,38], recipient CPCs may resist irradiation,
and their competition may further reduce myocyte regeneration
by marrow-derived precursors. While the rod-shaped GFP-
marked myocytes in the fetal myocardial tissue demonstrate
unequivocally that marrow can produce myocytes (Figure 2),
further development of our model may improve cardiac
repopulation by injected cells.
In summary, we here demonstrate myocyte regeneration from
marrow cells using a novel in vivo model of fetal myocardium
transplantation within the kidney capsule followed by lethal
irradiation plus marrow transplantation from GFP donor mice.
The level of regeneration of GFP-marked rod-shaped myocytes
was 35 fold greater in fetal myocardium than in the adult heart.
This novel in vivo model will be valuable for testing repopulating
abilities of many different potential cardiac progenitors and for
identifying which of multiple cardiac progenitor cell types can
Figure 2. Myocytes transdifferentiation from GFP
+ bone marrow in fetal heart inside kidney capsule. Immunostaining was performed at
12 months after fetal heart transplantation into kidney capsule and GFP
+ bone marrow transplantation. A: GFP
+ circulating cells homed into the fetal
heart, which was beating in the kidney capsule. B and C: Two cardiomyocytes (arrows) transdifferentiated from the GFP
+ bone marrow-origin cells.
Striation structure and co-localization of GFP (green) and a-sarcomeric actin (red) are evident.
doi:10.1371/journal.pone.0031099.g002
Figure 3. Myocyte transdifferentiation from GFP
+ bone marrow in adult heart 12 months after GFP
+ bone marrow transplantation.
Co-staining of GFP and a-sarcomeric actin reveals a cardiomyocyte also positive for GFP, suggesting that GFP
+ bone marrow cells differentiate into
cardiomyocyte in adult heart.
doi:10.1371/journal.pone.0031099.g003
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for distinguishing relative myocyte-producing abilities in compet-
itive repopulation comparisons [14–16,38].
Supporting Information
Video S1 Fetal heart beating in the kidney capsule (10 months
after the transplantation, separate video file downloadable from
online).
(WMV)
Figure S1 A mass of blood vessels (highlighted area)
was observed near the fetal heart at one week post fetal
heart transplantation to the kidney capsule.
(TIF)
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